newsfilter
← Latest News
GlobeNewswire·

PolyPid to Report Third Quarter 2026 Financial Results and Operational Highlights on November 11, 2026

  • PolyPid Ltd. (NASDAQ: PYPD) will report third quarter 2026 financial results & operational highlights before U.S. market open on Wednesday, November 11, 2026.
  • A conference call & webcast will be held at 8:30 AM Eastern Time to discuss results & provide business updates.
  • PolyPid is an innovative biopharmaceutical company developing long-acting, controlled-release drugs for surgical care & metabolic diseases.
  • Lead product D-PLEX₁₀₀ met primary & all key secondary endpoints in the Phase 3 SHIELD II trial for preventing surgical site infections.
  • Investor contact information includes Ori Warshavsky (908-858-5995, IR@Polypid.com) & Arx Investor Relations (polypid@arxhq.com).